Xoft
Company Details
Status: Public
Employees: 101-250
Location:
San Jose, California, United States
Type:
sample
sample
Technology:
sample
About: The Xoft® Electronic Brachytherapy System® is an isotope-free radiation treatment cleared by the FDA for use anywhere in the body, including non-melanoma skin cancer, brain tumors, early stage breast cancer, and gynecological cancers. It utilizes a proprietary miniaturized x-ray as the radiation source that delivers precise treatment directly to cancerous areas while sparing healthy tissue and organs. The Xoft System can be administered as a single course of radiation therapy during surgery in the form of intraoperative radiation therapy (IORT) or in the form of partial breast irradiation (APBI). The Xoft System does not require a shielded environment and the system’s relatively small size and mobility enable it to be used in virtually any clinical setting. A post-market study is underway to assess the safety and efficacy of IORT with the Xoft System. For more information about Xoft visit www.xoftinc.com.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Xoft | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.